Orchid Chemicals Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Orchid Chemicals Quarterly Results    (ORCHID)

Here are the latest quarterly results of Orchid Chemicals. For more details, see the Orchid Chemicals financial fact sheet and Orchid Chemicals share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Orchid Chemicals Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-18
3
Jun-18
3
Sep-18
3
Dec-18
3
Mar-19
3
Jun-19
3
Sep-19
3
Dec-19
8-Qtr Chart
Click to enlarge
Net Sales Rs m1,5581,3061,4251,4851,6211,3581,3101,286 
Other income Rs m1443631945526670 
Turnover Rs m1,5721,3491,4881,5031,6661,4091,3761,356 
Expenses Rs m2,2721,4491,4571,3601,6981,4521,3101,376 
Gross profit Rs m-714-3935125134-940-90 
Depreciation Rs m326328330328313314317316 
Interest Rs m01350000111 
Profit before tax Rs m-1,025-460-231-185-134-356-252-347 
Tax Rs m-1010000000 
Profit after tax Rs m-924-460-231-185-134-356-252-347 
Gross profit margin %-45.8-3.02.58.48.3-6.90.0-7.0 
Effective tax rate %9.90.00.00.00.00.00.00.0 
Net profit margin %-59.3-35.2-16.2-12.4-8.3-26.2-19.2-27.0 
Diluted EPS Rs -10.8 -5.4 -2.7 -2.2 -1.6 -4.2 -3.0 -4.1  
Diluted EPS (TTM) Rs -41.6 -33.5 -28.0 -21.1 -11.9 -10.6 -10.9 -12.8  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Orchid Chemicals 2QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   ALEMBIC PHARMA  WYETH  SANOFI INDIA  AUROBINDO PHARMA  VENUS REMEDIES  

Compare ORCHID PHARMA With:   ALEMBIC PHARMA  WYETH  SANOFI INDIA  AUROBINDO PHARMA  VENUS REMEDIES  

Compare ORCHID PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 136 Points Lower; Telecom and Automobile Stocks Witness Selling(Closing)

Indian share markets witnessed volatile trading activity throughout the day and ended marginally lower.

Views on news

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

More Views on News

Most Popular

My View on ITC (Fast Profits Daily)

Oct 23, 2020

What do the charts say about ITC?

PSU Banks Will Move Up Again (Profit Hunter)

Oct 27, 2020

My charts tell me PSU banks are set for a rebound.

PSU Stocks Are Looking Positive Now (Fast Profits Daily)

Oct 19, 2020

Has the market changed its opinion on PSUs?

One Cycle that Defines Everything in Markets (Profit Hunter)

Oct 23, 2020

Know this cycle to boost your profits in the market.

Markets are Always Right? (The Honest Truth)

Oct 30, 2020

Ajit Dayal on why you shouldn't let your guard down as an investor.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA SHARE PRICE


Jul 24, 2019 (Close)

TRACK ORCHID PHARMA

  • Track your investment in ORCHID PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA

ORCHID PHARMA - DIVIS LABORATORIES COMPARISON

COMPARE ORCHID PHARMA WITH

MARKET STATS